bioRxivBiochemistryPreprint
A revised 1.6 Å structure of the GTPase domain of the Parkinson’s disease-associated protein LRRK2 provides insights into mechanisms
C.-X. Wu, J. Liao, Y. Park, N. C. Hoang, V. A. Engel, L. Wan, M. Oh, R. Sanishvili, Y. Takagi, S. M. Johnson, M. Wang, M. Federici, R. J. Nichols, A. Bellina, X. Reed, M. R. Cookson, Q. Q. Hoang
Abstract
Leucine-rich repeat kinase 2 (LRRK2) is a large 286 kDa multi-domain protein whose mutation is a common cause of Parkinsons disease (PD). One of the common sites of familial PD-associated mutations occurs at residue Arg-1441 in the GTPase domain of LRRK2. Previously, we reported that the PD-associated mutation R1441H impairs the catalytic activity of the GTPase domain thereby traps it in a persistently \"on\" state. More recently, we reported that the GTPase domain of LRRK2 exists in a dynamic dimer-monomer equilibrium where GTP binding shifts it to the monomeric conformation while GDP binding shifts it back to the dimeric state. We also reported that all of the PD-associated mutations at Arg-1441, including R1441H, R1441C, and R1441G, impair the nucleotide-dependent dimer-monomer conformational dynamics of the GTPase domain. However, the mechanism of this nucleotide-dependent conformational dynamics and how it is impaired by the mutations at residue Arg-1441 remained unclear. Here, we report a 1.6 [A] crystal structure of the GTPase domain of LRRK2. Our structure has revealed a dynamic switch region that can be differentially regulated by GTP and GDP binding. This nucleotide-dependent regulation is impaired when residue Arg-1441 is substituted with the PD-associated mutations due to the loss of its exquisite interactions consisting of two hydrogen bonds and a {pi}-stacking interaction at the dimer interface.\n\nSignificance StatementMutations in LRRK2 are associated with familial Parkinsons disease, so understanding its mechanism of actions and how they are changed by the disease-associated mutations is important for developing therapeutic strategies. This paper describes an atomic structure of the G-domain of LRRK2 revealing that the conformational dynamics of the switch regions are potentially important for its normal function. It further shows that a disease-associated mutation could lock the G domain in a persistently active-like conformation, thus perturbing its normal function.
- organism: human
- assay: protein structure
- research focus: protein structure prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The structural basis for LRRK2's activation and autoinhibition
Amalia C. Villagran Suarez, Kathryn S. Hatch, … Andrés E. Leschziner·CellPeer-reviewed·Aug 10, 2026
- Structural basis for Parkinson's Disease-linked LRRK2's binding to microtubules
D. M. Snead, M. Matyszewski, … S. L. Reck-Peterson·bioRxiv·Jan 21, 2022
- 14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state
Juliana A. Martinez Fiesco, Alexandra G. Beilina, … Ping Zhang·Nature CommunicationsPeer-reviewed·Aug 5, 2025
- The in situ structure of Parkinson’s disease-linked LRRK2
R. Watanabe, R. Buschauer, … E. Villa·bioRxiv·Nov 10, 2019
- Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2
S. H. Schmidt, J.-H. Weng, … S. S. Taylor·bioRxiv·Jul 13, 2020
- Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism
B. K. Gilsbach, F. Y. Ho, … C. J. Gloeckner·bioRxiv·Jul 31, 2023